Search Results - "Reuser, Arnold J.J"
-
1
How to describe the clinical spectrum in Pompe disease?
Published in American journal of medical genetics. Part A (01-02-2013)Get full text
Journal Article -
2
Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse
Published in Neurobiology of disease (01-06-2004)“…Hearing deficit occurs in several lysosomal storage disorders but has so far not been recognized as a symptom of Pompe's disease (glycogen storage disease type…”
Get full text
Journal Article -
3
Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease
Published in Molecular therapy. Methods & clinical development (12-06-2020)“…Pompe disease is an autosomal recessive lysosomal storage disorder characterized by progressive muscle weakness. The disease is caused by mutations in the acid…”
Get full text
Journal Article -
4
The Natural Course of Infantile Pompe's Disease: 20 Original Cases Compared With 133 Cases From the Literature
Published in Pediatrics (Evanston) (01-08-2003)“…Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current developments toward enzyme replacement therapy are promising. The aim of our study…”
Get full text
Journal Article -
5
A new diagnostic assay for glycogen storage disease type II in mixed leukocytes
Published in Molecular genetics and metabolism (01-05-2006)“…We have established a new method for the enzymatic diagnosis of glycogen storage disease type II (Pompe disease or acid maltase deficiency) using mixed…”
Get full text
Journal Article -
6
Design and validation of a metabolic disorder resequencing microarray (BRUM1)
Published in Human mutation (01-07-2010)“…The molecular genetic diagnosis of inherited metabolic disorders is challenging. The diseases are rare, and most show locus heterogeneity. Hence, testing of…”
Get full text
Journal Article -
7
Structural modeling of mutant α-glucosidases resulting in a processing transport defect in Pompe disease
Published in Journal of human genetics (01-06-2009)“…To elucidate the mechanism underlying transport and processing defects from the viewpoint of enzyme folding, we constructed three-dimensional models of human…”
Get full text
Journal Article -
8
Survival and Prognostic Factors Prior to Enzyme Replacement Therapy in 302 Children and Adults with Pompe Disease
Published in Clinical therapeutics (01-06-2011)Get full text
Journal Article -
9
A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers
Published in Neuromuscular disorders : NMD (01-03-2011)“…Abstract We present a case of adult Pompe disease (acid maltase deficiency) with an uncommon clinical presentation characterized by severe fatigue and myalgia…”
Get full text
Journal Article -
10
Low bone mass in Pompe disease
Published in Bone (New York, N.Y.) (01-09-2010)“…Abstract Pompe disease is an inherited metabolic myopathy caused by deficiency of acid alpha-glucosidase. The introduction of enzyme replacement therapy as…”
Get full text
Journal Article -
11
A case of childhood Pompe disease demonstrating phenotypic variability of p.Asp645Asn
Published in Neuromuscular disorders : NMD (01-06-2004)“…A six-year-old child presented at 8 months of age with proximal muscle weakness and mild cardiac hypertrophy. Some α-glucosidase activity was detected in…”
Get full text
Journal Article -
12
The genotype-phenotype correlation in Pompe disease
Published in American journal of medical genetics. Part C, Seminars in medical genetics (15-02-2012)“…Pompe disease is an autosomal recessive lysosomal glycogen storage disorder that is caused by acid α‐glucosidase (GAA) deficiency and is due to pathogenic…”
Get full text
Journal Article -
13
GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry
Published in Human mutation (01-11-2019)“…Identification of variants in the acid α‐glucosidase (GAA) gene in Pompe disease provides valuable insights and systematic overviews are needed. We report on…”
Get full text
Journal Article -
14
Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease
Published in Journal of inherited metabolic disease (01-03-2015)“…Background Enzyme-replacement therapy (ERT) in Pompe disease—an inherited metabolic disorder caused by acid α-glucosidase deficiency and characterized in…”
Get full text
Journal Article -
15
Twenty-two novel mutations in the lysosomal ?-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II
Published in Human mutation (01-01-2004)“…Patients with glycogen storage disease type II (GSDII, Pompe disease) suffer from progressive muscle weakness due to acid ±-glucosidase deficiency. The disease…”
Get full text
Journal Article -
16
Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up
Published in Journal of inherited metabolic disease (01-03-2016)“…Summary Background Pompe disease is an inheritable metabolic disorder for which enzyme replacement therapy (ERT) has been available since 2006. Effects of ERT…”
Get full text
Journal Article -
17
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Published in Orphanet journal of rare diseases (27-03-2013)“…Pompe disease is a rare metabolic myopathy for which disease-specific enzyme replacement therapy (ERT) has been available since 2006. ERT has shown efficacy…”
Get full text
Journal Article -
18
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
Published in Orphanet journal of rare diseases (07-06-2012)“…Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficiency, acid maltase deficiency, OMIM # 232300) is an autosomal-recessive…”
Get full text
Journal Article -
19
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
Published in Orphanet journal of rare diseases (12-11-2012)“…Due partly to physicians' unawareness, many adults with Pompe disease are diagnosed with great delay. Besides, it is not well known which factors influence the…”
Get full text
Journal Article -
20
Glycogen storage disease type II: Genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry
Published in Human mutation (1998)“…Glycogen Storage Disease type II (GSDII) is caused by the deficiency of lysosomal α‐glucosidase (acid maltase). This paper reports on the characterization of…”
Get full text
Journal Article